How to treat endocardial sclerosis?

summary

Endocardial fibroelastosis; Also known as endocardial sclerosis, its etiology is not yet clear. For children with primary cardiomyopathy in a more common, also known as primary endocardial fibroelastosis. Is an unexplained infant disease, breathing difficulties, lips cyanosis, tachycardia, hepatosplenomegaly, heart failure and other symptoms, mortality is very high, so how to treat endocardial sclerosis? Let's talk about it.

How to treat endocardial sclerosis?

Endocardial fibroelastosis is known as endocardiosclerosis in children. Its main pathological change is the proliferation of subendocardial elastic fibers and collagen fibers, and the lesion is mainly left ventricle. Most of the cases are within 1 year old, and the cause of discontinuation is not clear. Some think it is related to virus infection, myocardial ischemia or hypoxia, genetic metabolism, etc

Treatment is mainly symptomatic treatment, with digitalis control heart failure, the effect is OK, a considerable number of children were clinically cured. There is the possibility of cure, it is recommended that parents should go to the specialized hospital in time, if the child has respiratory tract infection, it should be treated as soon as possible

Some people think that myocarditis and endocardial fibroelastosis may be the manifestations of the same disease in different periods. Myocarditis is the precursor of endocardial fibroelastosis. Heart type glycogen accumulation disease, mucopolysaccharidosis, and carnitine deficiency can cause this disease.

matters needing attention

If the disease is not treated, most of them die before 2 years old. For digitalis patients with good therapeutic effect and long-term adherence to treatment, the prognosis is good and recovery is possible. The prognosis of the disease is serious, and the mortality rate is about 20% - 25%. The patients with older onset age and good response to digitalis treatment have better prognosis and can be cured clinically.